The FDA has approved lebrikizumab (Ebglyss; Eli Lilly) as a new first-line biologic treatment for patients aged 12 and older with moderate to severe atopic dermatitis (AD). The FDA approved ...

The single-dose 300 mg/2 mL autoinjector is now available as an additional injection choice when administering Adbry for the treatment of moderate-to-severe atopic dermatitis (AD) in adults.

Adbry is currently indicated in the U.S. for patients 12 years and older with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription ...

Eli Lilly has announced that the US Food and Drug Administration (FDA) has approved its targeted IL-13 inhibitor Ebglyss (lebrikizumab-lbkz) to treat moderate-to-severe atopic dermatitis (AD). The ...

First, YouTube subjected viewers to longer unskippable ads. Now, not even pausing your screen will let users escape. The Google-owned platform confirmed Thursday that it has “widely rolled out ...

Hundreds of thousands of low-income Americans were unknowingly signed up for government-subsidized health insurance, often lured by social-media ads falsely promising cash for daily expenses ...

In two identical phase 3 trials known as ADvocate 1 and ADvocate 2, researchers randomly assigned 851 patients with moderate to severe AD in a 2:1 ratio to receive either lebrikizumab at a dose of ...

Vice President Kamala Harris’ campaign on Friday launched a new television ad seeking to tie former President Donald Trump to North Carolina’s Republican gubernatorial nominee Mark Robinson ...

The news of the ad was first shared with ABC News. Vice President Kamala Harris' campaign is releasing a new ad on Friday featuring her closing statement from the ABC News debate when she called ...

Search Engine Land » PPC » Amazon Ads launches AI-powered video Chat with SearchBot Please note that your conversations will be recorded. SearchBot: I am trained with Search Engine Land content.